Search
 
CIFAR VIRTUAL TALKS

The sick & the healthy: How can we help each other?

 
August 20, 2020
1:30 PM EST (45 min)

Location:
Virtual Meeting

 

 

About

What can we learn from the 19th century technique of using antibody-rich plasma from survivors to treat the sick? What is the state of affairs with respect to international vaccine development? What unites these two tracks and what separates them?

CIFAR President & CEO Alan Bernstein and Arturo Casadevall, chair of the advisory committee of CIFAR’s Fungal Kingdom: Threats & Opportunities research program (Johns Hopkins University), will discuss the state of rapid research into treatment and protection of COVID-19 patients. Dr. Casadevall is also chair of the US-based National COVID-19 Convalescent Plasma Project, which recently received $35 million from the U.S. Department of Defense for two nationwide clinical trials to test the effectiveness of giving blood plasma from previously infected individuals to people in high-risk groups or with mild symptoms of COVID-19. 

 

Alan Bernstein is President & CEO of ClFAR, responsible for developing and leading the institute's overall strategic direction. He served previously as executive director of the Global HIV Vaccine Enterprise in New York, an international alliance of funders charged with accelerating the search for an HIV vaccine. In May 2020, he was appointed to the Canada’s COVID-19 Vaccine Task Force.  A much sought after science advisor in countries around the world, his contributions to science have been recognized with numerous awards and honorary degrees, including Officer of the Order of Canada, Order of Ontario, induction into the Canadian Medical Hall of Fame, and the 2017 Henry Friesen International Prize in Health Research. 


Arturo Casadeval
is a Bloomberg Distinguished Professor of Molecular Microbiology & Immunology and Infectious Diseases at the Johns Hopkins Bloomberg School of Public Health and Johns Hopkins School of Medicine. He is a world renowned expert in infectious disease research, with a focus on fungal and bacterial pathogenesis and basic immunology of antibody structure-function. He is Advisory Committee Chair of CIFAR's Fungal Kingdom: Threats & Opportunities program, and established the National COVID-19 Convalescent Plasma Project.

 

This event is offered in English. French subtitles will be available on the post-event recording.